查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861523

切片穿刺針市場按類型、手術、類別、材質、採購管道、應用和最終用戶分類－全球預測（2025-2032 年）

Biopsy Needles Market by Type, Procedure, Category, Material, Purchasing Channel, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，切片穿刺針市場規模將達到 11.695 億美元，複合年成長率為 5.96%。

關鍵市場統計數據
基準年 2024 7.3549億美元
預計年份：2025年 7.7771億美元
預測年份 2032 11.695億美元
複合年成長率 (%) 5.96%

本文策略性地介紹了切片穿刺針創新和採購為何與不斷發展的診斷路徑、臨床工作流程以及醫療環境的轉型直接相關。

切片穿刺針是現代診斷流程中不可或缺的組成部分，它使臨床醫生能夠以微創方式提取組織並做出明確的臨床決策。過去十年，影像引導、針體設計和材料科學的不斷進步，拓展了經皮切片檢查術在各個器官系統的臨床應用範圍。隨著臨床路徑向更早期、影像主導的檢測和精準醫療方向發展，活體組織切片針本身已不再只是一個被動的工具；它成為了手術效率、安全性和後續診斷產量的交匯點。因此，製造商、臨床醫生和採購經理必須以全面的方式評估產品性能、手術適用性和生命週期經濟性。此外，從住院病房到門診手術中心和診斷診所，不斷變化的醫療環境正在改變設備需求和服務預期，促使製造商最佳化其產品系列和商業策略。在此背景下，相關人員應優先考慮清晰了解手術要求、臨床醫生工作流程以及設備特性與診斷結果之間的相互作用。這樣做，產品開發和商業化策略可以更好地與現代切片檢查實踐的實際情況以及臨床醫生、患者和醫療保健系統不斷變化的期望相一致。

診斷影像、即時護理轉型以及監管和數位化需求的融合正在推動重大變革，重新定義切片穿刺針的研發和採購。

受技術創新、臨床實踐變革以及對診斷準確性和患者體驗日益成長的期望所驅動，切片穿刺針領域正經歷著變革性的轉變。針體形狀、塗層和成像相容設計的進步，在減少取樣誤差和手術時間的同時，也拓展了臨床醫師可進行的微創手術範圍。同時，真空抽吸系統和改進的影像導引平台的日益普及，正在重塑臨床醫生的選擇，使得在門診環境中進行更複雜的組織取樣成為可能。醫療保健從住院轉向門診，推動了對快速安裝、一次性使用且無菌、庫存管理簡便的針體的需求。同時，數位化整合也在不斷發展，手術資料收集、設備可追溯性以及與電子健康記錄的互通性，正成為系統級採購決策中的差異化因素。監管機構對安全性和可追溯性的重視持續推動著品質要求的提升，而商業策略則越來越強調捆綁式產品、服務協議和培訓。因此，能夠將臨床證據生成、實用治療方案和可擴展生產相結合，以應對臨床醫生效率和醫療保健系統成本控制這兩大壓力的公司，正在獲得競爭優勢。

對 2025 年美國關稅變化對針頭價值鏈的採購、製造決策、購買趨勢和供應鏈韌性的影響進行全面分析。

2025年美國關稅調整的累積影響已對切片穿刺針針價值鏈造成了顯著壓力，促使製造商和採購商重新評估其採購、定價和庫存策略。某些進口零件和子組件的關稅上調增加了依賴跨境供應鏈的製造商的投入成本。金屬合金、精密加工零件和某些等級的聚合物受到的影響尤其嚴重。為此，許多供應商加快了在地採購和近岸外包的步伐，以降低貿易政策波動帶來的風險。同時，一些工程團隊尋求替代產品設計方案，對零件進行重新分類，以最大限度地減少關稅的影響。醫院和門診醫療機構已重組採購合約並延長競標週期，以確保在成本結構變化的情況下供應的連續性。集團採購組織也加強了談判，以維持價格的可預測性。同時，醫療設備製造商透過提高生產效率、自動化以及與供應商更緊密的合作來控制成本，從而減輕了下游臨床採購部門的壓力。重點，這些調整因產品類型而異。材料清單(BOM) 簡單的耗材比整合電子元件和獨特子組件的複雜可重複使用系統更容易重新配置。展望未來，關稅主導的獎勵加速了供應商整合和區域投資決策，同時也凸顯了供應鏈透明度、多源採購和合約彈性對於切片穿刺針針生態系統中相關人員的重要性。

詳細的細分分析揭示了類型、處理方式、類別、材質、採購管道、應用和最終用戶等方面的差異對產品、定價和上市策略的影響。

細分市場層面的趨勢分析揭示了清晰的需求模式和策略重點，這些資訊可用於制定產品藍圖和進行商業性細分。按類型分類，市場可分為單針和雙針，每種類型都滿足不同的臨床醫生偏好和組織採集技術。因此，設計最佳化和臨床醫生培訓對於在專科診所的推廣應用至關重要。依手術方式分類，穿刺切片檢查、空芯針切片檢查和真空輔助切片檢查分別涉及不同的技術要求和臨床路徑。因此，器械開發商必須根據手術目的調整針頭形狀、管腔特性以及與輔助輔助器具的兼容性。按類別分類，一次性產品和可重複使用產品在經濟性和感染控制方面存在差異，這會影響醫院和門診手術中心的採購決策。生命週期成本、滅菌通訊協定和監管要求會影響醫療機構是優先考慮一次性產品的便利性還是可重複使用產品的資本投入。按材質，金屬和塑膠產品在剛性、影像偽影和製造成本方面各有優劣。這需要根據手術流程和臨床醫生的操作預期，精心選擇合適的材質。按採購管道分類，隨著醫院和診所將傳統的直銷關係與電子採購和數位市場結合，線上和線下銷售日益並存。這也正在改變銷售結構和售後支援。按應用領域分類，乳房切片、腎臟切片檢查、肝臟切片檢查、切片檢查和攝護腺切片檢查檢查各自具有獨特的操作和取樣限制，這決定了穿刺針的長度、切割機制以及與導航系統的兼容性。按最終用戶分類，門診手術中心、診斷診所和醫院對性能特徵、服務水平和採購週期有著不同的優先考慮，因此，細分市場的商業化策略必須調整通訊、管道投資和臨床醫生參與度，以反映最終用戶的實際情況。

區域診斷和商業性特徵會影響產品適應症、監管方式、製造地以及在全球市場的採用模式。

區域趨勢對監管路徑、臨床實踐模式和生產策略有顯著影響，從而創造了不同的機會和風險。在美洲，完善的臨床指南、影像導引手術的高普及率以及成熟的支付方環境，都為先進針頭設計和整合手術系統的快速推廣提供了支援。同時，監管路徑著重於上市後監測和醫療設備可追溯性。在歐洲、中東和非洲，監管環境的多樣性和報銷政策的波動性，要求區域性的商業化策略，在集中核准、國家層面的市場進入規劃和有針對性的臨床證據生成之間取得平衡。在亞太地區，不斷擴展的診斷基礎設施、對本地生產的投資以及門診護理模式的快速普及正在推動市場成長，尤其是對經濟高效的一次性產品和可擴展培訓項目的需求。供應鏈配置和關稅風險因地區而異，影響著組件採購、製造地和庫存策略的決策。此外，不同地區對可重複使用解決方案和一次性解決方案的偏好，以及門診手術中心和獨立診斷診所的普及程度，都將影響長期的產品藍圖和服務模式。因此，各公司應根據各地區的結構和臨床特徵調整其研發、監管和商業化重點，以最大限度地提高相關性和普及率。

公司及競爭對手分析重點闡述現有企業、專業創新者和策略聯盟如何推動產品系列的差異化、提高產品採用率以及以服務主導的客戶維繫。

切片穿刺針市場的競爭格局複雜，既有成熟的醫療設備製造商，也有專注於創新領域的專業企業，還有新興的利基供應商。成熟的醫療設備製造商擁有廣泛的分銷網路、完善的服務和穩固的臨床醫生關係，這加速了漸進式創新技術的推廣應用。同時，專注於利基市場的企業則傾向於透過獨特的針體幾何形狀、新型材料和針對特定手術的輔助器具來打造差異化技術。規模較小的公司通常更注重臨床合作中的靈活性和客製化配置。常見的策略措施包括：透過有針對性的收購來拓展手術產品組合；與影像和引導系統供應商合作，提供捆綁式解決方案；以及投資臨床證據以支持其性能對比聲明。售後服務（培訓、器械再處理協助、耗材供應協議）是重要的收入來源和客戶維繫手段，尤其是在手術量和臨床醫生偏好起著關鍵作用的環境中。此外，投資於模組化設計和互通介面的公司在與尋求跨多個臨床環境實現標準化的醫療系統合作時，也具有顯著優勢。對於新參與企業和老牌公司而言，成功都需要在以下幾個方面取得平衡：檢驗的臨床療效、具有韌性的供應鏈、清晰的服務提案以及在醫院和門診處方集上的持續存在。

針對製造商和買家的具體策略建議，旨在協調產品設計、供應鏈韌性、臨床證據開發和通路策略，以確保持續競爭力。

產業領導者應採取一系列協調一致的策略行動，以贏得臨床青睞、應對成本壓力並增強供應可靠性。首先，應優先開發以醫療服務提供者為中心的產品，使針頭設計和操作相容性與已證實的臨床療效和易用性相匹配，從而促進產品在醫院和門診醫療機構的快速普及。其次，應透過多地點採購、盡可能選擇近岸外包以及強力的合約保護來增強供應鏈韌性，以降低貿易政策和關稅波動的影響。同時，應最佳化商業模式以適應不斷變化的採購行為，包括更深入地整合電子採購系統、加強數位化銷售支援以及為門診手術中心和診斷診所提供產品客製化服務。此外，還應制定強力的臨床證據項目，以展示產品在常見應用領域的性能對比，並開發可擴展的培訓和支援服務，以減少操作差異。定價策略應靈活，對高效能設備採用基於價值的定價策略，並對大批量應用提供具有成本競爭力的耗材選項。最後，我們將尋求與影像和導航設備供應商建立策略合作夥伴關係，儘早與支付方溝通報銷證據需求，並考慮採用模組化產品架構，以便快速回應臨床回饋和監管變化。這些措施的共同實施將提高市場應對力，保障利潤率，並加強與醫療服務提供者的關係。

本研究採用穩健的混合方法研究途徑，結合臨床醫生訪談、採購歷史檢驗、監管和臨床文獻回顧以及三角驗證技術，以確保研究結果的可靠性。

我們的研究途徑結合了結構化的初步調查（對象包括臨床醫生、採購主管和行業高管）、系統性回顧同行評審的臨床文獻以及對監管文件和醫療設備召回資料庫的分析。初步研究包括對介入放射科醫生、病理學家和手術全期護理師的深入訪談，以了解手術流程的細微差別、臨床醫生的偏好以及尚未滿足的需求。與採購和供應鏈相關人員的對話，讓我們深入了解了競標趨勢、庫存管理實踐以及如何應對關稅波動導致的成本變化。二次研究涵蓋了醫療設備規格、監管指南、臨床試驗註冊資訊和製造商產品資料，以檢驗有關技術選擇和相容性的說法。我們採用資料三角測量法，將質性研究結果與監管措施和臨床結果進行匹配，並使用分析框架整合供應鏈、監管和商業性因素的影響。品質保證程序包括與專家評審小組和臨床醫生進行迭代檢驗，以確保研究結果的實用性和準確性。限制因素和注意事項，例如區域實踐模式的潛在差異以及可能隨著時間推移而改變商業性條件的不斷變化的貿易和監管政策，也得到了明確的闡述。

經營團隊結論綜合闡述了臨床、商業性和供應方面的因素如何共同作用，從而確定切片穿刺針針利益相關人員的策略重點。

累積分析表明，切片穿刺針仍然是臨床表現、手術效率和供應鏈策略的關鍵環節。技術進步和不斷變化的醫療環境正在重新定義產品預期，而政策和貿易趨勢則迫使製造商和採購商重新調整籌資策略和成本控制措施的優先順序。細分市場分析強調了針對特定手術的設計、最佳化的通路和終端用戶服務模式的重要性。區域監管和市場推廣規劃必不可少，而那些能夠將臨床證據、互通性解決方案和強大的生產基地相結合的公司將在競爭環境中獲得優勢。隨著相關人員應對這些變化，最成功的機構將整合以臨床醫生主導的創新、嚴謹的供應鏈規劃以及能夠反映醫院系統和門診醫療機構實際情況的靈活商業模式。這些基礎性舉措將使公司和醫療系統能夠在保持營運和財務穩定的同時，改善診斷結果。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在個人化癌症治療計劃中，核心針穿刺活體組織切片設備的應用日益廣泛
  • 整合人工智慧引導系統以實現精準的切片穿刺針定位
  • 感染控制和監管合規措施正在推動一次性用品的需求。
  • 開發冷凍活體組織切片切片穿刺針技術以改善介入性肺病護理中的肺組織取樣。
  • 推出可操控、軟性切片穿刺針，專為微創手術中難以觸及的解剖結構而最佳化設計。
  • 擴大液態生物檢體的替代方案，以減少腫瘤診斷過程中對傳統針刺活體組織切片的依賴
  • 由醫療設備製造商和影像軟體供應商合作開發的即時針頭導航解決方案
  • 生物相容性鎳鈦諾和聚合物複合材料的進步提高了切片穿刺針的耐用性，並增強了患者的安全性。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章切片穿刺針市場（按類型分類）

  • 單眼針
  • 特姆諾針

第9章 依手術方式切片穿刺針針市場

  • 穿刺切片檢查
  • 核心切片檢查
  • 真空輔助切片檢查

第10章切片穿刺針市場（按類別分類）

  • 一次性的
  • 可重複使用的

第11章 按材料切片穿刺針市場

  • 金屬
  • 塑膠

第12章 按採購管道切片穿刺針市場

  • 線下銷售
  • 線上銷售

第13章 按應用分類的切片穿刺針市場

  • 乳房切片
  • 切片檢查
  • 肝臟切片檢查
  • 切片檢查
  • 攝護腺切片檢查

第14章 按最終用戶分類的切片穿刺針市場

  • 門診手術中心
  • 診斷診所
  • 醫院

第15章 各地區切片穿刺針市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章切片穿刺針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國切片穿刺針市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Argon Medical Devices, Inc.
    • B. Braun SE
    • Becton, Dickinson and Company
    • Biomedical Srl
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Cook Group Incorporated
    • Doctor Japan Co., Ltd.
    • Freudenberg Medical, LLC
    • Geotek Medical
    • Hologic, Inc.
    • Inrad, Inc.
    • IZI Medical Products
    • Medax Srl
    • Medi-Tech Devices Pvt. Ltd.
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Mermaid Medical Group
    • Olympus Corporation
    • Pajunk GmbH Medizintechnologie
    • Point Blank Medical
    • Remington Medical
    • Stryker Corporation
    • Volkmann MedizinTechnik GmbH
    • weLLgo Medical Products GmbH
Product Code: MRR-69324464D211

The Biopsy Needles Market is projected to grow by USD 1,169.50 million at a CAGR of 5.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 735.49 million
Estimated Year [2025] USD 777.71 million
Forecast Year [2032] USD 1,169.50 million
CAGR (%) 5.96%

Strategic introduction to why biopsy needle innovation and procurement align directly with evolving diagnostic pathways, clinical workflows and care setting transformation

Biopsy needles represent a foundational component of modern diagnostic pathways, enabling clinicians to obtain tissue with minimal invasiveness while informing definitive clinical decisions. Over the past decade, incremental advances in imaging guidance, needle design and materials science have expanded the clinical scope of percutaneous biopsy procedures across organ systems. As clinical pathways shift toward earlier, image-driven detection and precision medicine, the needle itself has become more than a passive instrument: it is a convergence point for procedural efficiency, safety, and downstream diagnostic yield. Consequently, manufacturers, clinicians and procurement leaders must evaluate product performance, procedural fit and lifecycle economics in tandem. Moreover, evolving care settings-from inpatient hospital suites to ambulatory surgical centers and diagnostic clinics-alter device demand profiles and service expectations, prompting manufacturers to refine portfolios and commercial approaches. In this context, stakeholders should prioritize a clear understanding of procedural requirements, clinician workflows and the interplay between device attributes and diagnostic outcomes. By doing so, product development and commercialization strategies can better align with the operational realities of contemporary biopsy practice and with the evolving expectations of clinicians, patients and health systems.

High-impact shifts redefining biopsy needle development and procurement driven by imaging integration, site-of-care migration, and regulatory and digital imperatives

The biopsy needle landscape is undergoing transformative shifts driven by technological innovation, changing site-of-care dynamics and heightened expectations for diagnostic accuracy and patient experience. Advancements in needle geometries, coatings and imaging-compatible designs are reducing sampling error and procedure time while expanding the range of minimally invasive interventions clinicians can perform. At the same time, broader adoption of vacuum-assisted systems and improvements in image-guidance platforms are reshaping clinician preferences and enabling more complex tissue sampling in outpatient settings. Shifting care from inpatient to ambulatory environments has prompted demand for needles optimized for rapid setup, single-use sterility and simplified inventory management. In parallel, digital integration is increasing: procedural data capture, device traceability and interoperability with electronic medical records are becoming differentiators for system-level purchasing decisions. Regulatory emphasis on safety and traceability continues to elevate quality requirements, while commercial strategies now place greater weight on bundled offerings, service contracts and training. As a result, the competitive playing field rewards firms that combine clinical evidence generation, practical procedural solutions and scalable manufacturing, enabling them to meet the simultaneous pressures of clinician efficacy and health system cost containment.

Comprehensive analysis of how United States 2025 tariff changes reshaped sourcing, manufacturing decisions, procurement dynamics, and supply chain resilience across the needle value chain

The cumulative implications of tariff adjustments instituted by the United States in 2025 have introduced measurable pressure across the biopsy needle value chain, prompting manufacturers and buyers to reassess sourcing, pricing and inventory strategies. Increased duties on certain imported components and subassemblies have elevated input costs for manufacturers that rely on cross-border supply networks, particularly for metal alloys, precision-machined parts and specific polymer grades. In response, many suppliers accelerated localization and nearshoring initiatives to reduce exposure to trade policy volatility, while some engineering teams explored product design alternatives to shift component classification and minimize tariff impact. Hospitals and ambulatory providers reacted by revisiting procurement contracts and extending tender cycles to secure supply continuity under changed cost structures, and group purchasing organizations intensified negotiations to retain predictable pricing. Simultaneously, device companies pursued cost containment through production efficiency, automation and closer vendor partnerships, which moderated downstream pressure on clinical purchasers. Importantly, these adaptations varied by product category: disposable items with simple bill-of-materials were easier to reconfigure than complex reusable systems with integrated electronics or proprietary subcomponents. Looking forward, tariff-driven incentives accelerated supplier consolidation and regional investment decisions, while also reinforcing the importance of supply chain transparency, multi-origin sourcing and contractual flexibility for stakeholders across the biopsy needle ecosystem.

In-depth segmentation insight clarifying how type, procedure, category, material, purchasing channel, application and end-user distinctions shape product, pricing and go-to-market choices

Segment-level dynamics reveal distinct demand patterns and strategic priorities that should inform product roadmaps and commercial segmentation. Based on Type, the market differentiates between monopty needle and temno needle, each serving unique clinician preferences and tissue-sampling techniques; design optimization and clinician training are therefore critical for adoption within specialty practices. Based on Procedure, aspiration biopsy, core biopsy and vacuum-assisted biopsy follow different technical requirements and clinical pathways, so device developers must match needle geometry, inner lumen characteristics and compatibility with procedural accessories to procedural intent. Based on Category, disposable and reusable options carry divergent economic and infection-control implications, which impacts purchasing decisions by hospitals and ambulatory surgical centers; lifecycle costs, sterilization protocols and regulatory requirements influence whether institutions favor single-use convenience or reusable capital investments. Based on Material, metal and plastic constructions offer trade-offs in rigidity, imaging artifact and manufacturing cost, requiring careful material selection aligned to procedural contexts and clinician handling expectations. Based on Purchasing Channel, offline sales and online sales increasingly coexist as hospitals and clinics blend traditional direct sales relationships with eProcurement and digital marketplaces, changing salesforce models and aftersales support. Based on Application, breast biopsy, kidney biopsy, liver biopsy, lung biopsy and prostate biopsy each impose specific access and sampling constraints, shaping needle length, cutting mechanisms and compatibility with guidance systems. Based on End User, ambulatory surgical centers, diagnostic clinics and hospitals prioritize different performance attributes, service levels and procurement cycles, so segmentation-aware commercialization strategies must adapt messaging, channel investment and clinician engagement to reflect end-user operational realities.

Regional diagnostic and commercial nuances that influence product adaptation, regulatory approach, manufacturing footprints and adoption patterns across global markets

Regional dynamics exert meaningful influence on regulatory pathways, clinician practice patterns and manufacturing strategies, producing differentiated opportunities and risks. In the Americas, established clinical guidelines, high adoption of image-guided procedures and a well-developed payer environment support rapid uptake of advanced needle designs and integrated procedural systems, while regulatory pathways emphasize post-market surveillance and device traceability. In Europe, Middle East & Africa, regulatory diversity and variable reimbursement landscapes mean commercialization approaches must be regionally tailored, balancing centralized approvals with country-level market access planning and targeted clinical evidence generation. In Asia-Pacific, growth is being driven by expanding diagnostic infrastructure, investments in local manufacturing and rapid adoption in outpatient care models, with particular demand for cost-efficient disposables and scalable training programs. Across all regions, supply chain configurations and tariff exposures differ, influencing decisions about component sourcing, manufacturing location and inventory strategy. Additionally, regional preferences for reusable versus disposable solutions and the penetration of ambulatory surgical centers versus standalone diagnostic clinics shape long-term product roadmaps and service models. Consequently, companies should align R&D, regulatory and commercial priorities with the specific structural and clinical characteristics of each region to maximize relevance and uptake.

Corporate and competitive analysis revealing how legacy manufacturers, focused innovators and strategic partnerships drive differentiation, adoption and service-led retention across product portfolios

Competitive dynamics in the biopsy needle arena reflect a mix of legacy device manufacturers, specialized innovators and emerging niche suppliers. Established medical device manufacturers maintain broad distribution networks, integrated services and established clinician relationships that can accelerate adoption of incremental innovations. Conversely, focused niche players often drive technical differentiation through proprietary needle geometries, novel materials and procedure-specific adjuncts, while smaller firms typically emphasize agility in clinical collaboration and custom configurations. Strategic behaviors observed across companies include targeted acquisitions to augment procedural portfolios, partnerships with imaging and guidance system providers to deliver bundled solutions, and investments in clinical evidence to support comparative performance claims. Aftermarket services-training, instrument reprocessing support and consumable supply agreements-have become important revenue and retention levers, particularly in settings where procedure volume and clinician preference exert heavy influence. Moreover, companies that invest in modular designs and interoperable interfaces have an advantage when engaging health systems seeking to standardize across multiple sites of care. For market entrants and incumbents alike, successful players will balance clinical validation, supply chain robustness and a clear service proposition to secure durable placement in hospital and outpatient formularies.

Actionable strategic recommendations for manufacturers and purchasers to align product design, supply chain resilience, clinical evidence development and channel strategies for sustained competitiveness

Industry leaders should pursue a coordinated set of strategic actions to capture clinical preference, manage cost pressure and strengthen supply reliability. First, prioritize clinician-centered product development that aligns needle design and procedure compatibility with documented clinical outcomes and ease-of-use, enabling faster uptake in both hospital and outpatient settings. Next, invest in supply chain resilience through multi-origin sourcing, nearshoring where feasible and stronger contractual protections to mitigate trade-policy and tariff volatility. Simultaneously, refine commercial models to reflect evolving purchasing behaviors by expanding eProcurement integration, enhancing digital sales enablement and tailoring offerings for ambulatory surgical centers and diagnostic clinics. Additionally, build robust clinical-evidence programs that demonstrate comparative performance across commonly performed applications, while also creating scalable training and support services to reduce procedural variability. Pricing strategies should be flexible, incorporating value-based pricing for high-performance devices and cost-competitive disposable options for volume-driven applications. Finally, pursue strategic partnerships with imaging and guidance vendors, engage with payers early on reimbursement evidence needs, and consider modular product architectures to respond rapidly to clinical feedback and regulatory changes. Together, these measures will improve market responsiveness, protect margins and strengthen institutional relationships.

Robust mixed-methods research approach combining clinician interviews, procurement validation, regulatory and clinical literature review plus triangulation for high-integrity insights

The research approach combined structured primary engagement with clinicians, procurement leads and industry executives, systematic review of peer-reviewed clinical literature and analysis of regulatory filings and device recall databases. Primary inputs included in-depth interviews with interventional radiologists, pathologists and perioperative nurses to capture procedural nuances, clinician preferences and unmet needs. Procurement and supply chain conversations provided insight into tender dynamics, inventory practices and responses to tariff-driven cost changes. Secondary research encompassed technical device specifications, guidance from regulatory agencies, clinical trial registries and manufacturer product literature to validate engineering choices and compatibility claims. Data triangulation methods were applied to cross-check qualitative insights against regulatory actions and clinical outcomes, and analytic frameworks were used to synthesize supply chain, regulatory and commercial implications. Quality assurance steps included expert review panels and iterative validation with practicing clinicians to ensure practical relevance and accuracy. Limitations and caveats were explicitly documented, including potential variability across local practice patterns and the evolving nature of trade and regulatory policy that may alter commercial conditions over time.

Executive conclusion synthesizing how clinical, commercial and supply-side forces converge to define strategic priorities for biopsy needle stakeholders

The cumulative analysis underscores that biopsy needles remain a critical intersection of clinical performance, procedural efficiency and supply chain strategy. Technological progress and shifting care settings are redefining product expectations, while policy and trade developments are compelling manufacturers and purchasers to reprioritize sourcing and cost-management tactics. Segmentation insights highlight the need for procedure-specific design, channel-tailored commercialization and end-user-aware service models. Regional nuances demand customized regulatory and market access planning, and competitive dynamics reward firms that combine clinical evidence, interoperable solutions and resilient manufacturing footprints. As stakeholders navigate these changes, the most successful organizations will integrate clinician-led innovation, disciplined supply chain planning and flexible commercial models that reflect the realities of both hospital systems and outpatient providers. These foundational actions will position companies and health systems to improve diagnostic outcomes while maintaining operational and financial stability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of core needle biopsy devices for personalized oncology treatment planning
  • 5.2. Integration of artificial intelligence guidance systems in biopsy needle placement for enhanced accuracy
  • 5.3. Rising demand for single-use disposable biopsy needles driven by infection control and regulatory compliance incentives
  • 5.4. Development of cryobiopsy needle techniques for improved lung tissue sampling in interventional pulmonology practice
  • 5.5. Emergence of steerable and flexible biopsy needles optimized for challenging anatomical site access in minimally invasive procedures
  • 5.6. Expansion of liquid biopsy alternatives reducing reliance on traditional needle sampling in oncology diagnostics pipelines
  • 5.7. Collaborative partnerships between medical device manufacturers and imaging software providers for real-time needle navigation solutions
  • 5.8. Advancements in biocompatible nitinol and polymer blend materials enhancing biopsy needle durability and patient safety profiles

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopsy Needles Market, by Type

  • 8.1. Monopty Needle
  • 8.2. Temno Needle

9. Biopsy Needles Market, by Procedure

  • 9.1. Aspiration Biopsy
  • 9.2. Core Biopsy
  • 9.3. Vacuum-Assisted Biopsy

10. Biopsy Needles Market, by Category

  • 10.1. Disposable
  • 10.2. Reusable

11. Biopsy Needles Market, by Material

  • 11.1. Metal
  • 11.2. Plastic

12. Biopsy Needles Market, by Purchasing Channel

  • 12.1. Offline Sales
  • 12.2. Online Sales

13. Biopsy Needles Market, by Application

  • 13.1. Breast Biopsy
  • 13.2. Kidney Biopsy
  • 13.3. Liver Biopsy
  • 13.4. Lung Biopsy
  • 13.5. Prostate Biopsy

14. Biopsy Needles Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Diagnostic Clinics
  • 14.3. Hospitals

15. Biopsy Needles Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Biopsy Needles Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Biopsy Needles Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Argon Medical Devices, Inc.
    • 18.3.2. B. Braun SE
    • 18.3.3. Becton, Dickinson and Company
    • 18.3.4. Biomedical Srl
    • 18.3.5. Boston Scientific Corporation
    • 18.3.6. Cardinal Health, Inc.
    • 18.3.7. Cook Group Incorporated
    • 18.3.8. Doctor Japan Co., Ltd.
    • 18.3.9. Freudenberg Medical, LLC
    • 18.3.10. Geotek Medical
    • 18.3.11. Hologic, Inc.
    • 18.3.12. Inrad, Inc.
    • 18.3.13. IZI Medical Products
    • 18.3.14. Medax Srl
    • 18.3.15. Medi-Tech Devices Pvt. Ltd.
    • 18.3.16. Medtronic PLC
    • 18.3.17. Merit Medical Systems, Inc.
    • 18.3.18. Mermaid Medical Group
    • 18.3.19. Olympus Corporation
    • 18.3.20. Pajunk GmbH Medizintechnologie
    • 18.3.21. Point Blank Medical
    • 18.3.22. Remington Medical
    • 18.3.23. Stryker Corporation
    • 18.3.24. Volkmann MedizinTechnik GmbH
    • 18.3.25. weLLgo Medical Products GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPSY NEEDLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. GCC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 286. GCC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 287. GCC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 288. GCC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 289. GCC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. GCC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. GCC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. GCC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. GCC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. GCC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. GCC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 334. G7 BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 335. G7 BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 336. G7 BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 337. G7 BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 338. G7 BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 339. G7 BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 340. G7 BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 341. G7 BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. G7 BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. G7 BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. G7 BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 346. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 347. NATO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. NATO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. NATO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 350. NATO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 351. NATO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 352. NATO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 353. NATO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 354. NATO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 355. NATO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 356. NATO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 357. NATO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. NATO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 359. NATO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 360. NATO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 361. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 362. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 363. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 201